Loading clinical trials...
Loading clinical trials...
To assess the frequency and risk factors of decreased bone mineral density (BMD) and vertebral fractures in Danish patients with sarcoidosis.
An increased risk of bone fracture has been found in patients with sarcoidosis. Some data showed that the risk of fracture was limited to patients treated with glucocorticoid but data are conflicting and not all studies can prove an increased risk of fracture or bone mineral loss in sarcoidosis.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Aarhus University Hospital. Dep. of Respiatory Diseases and Allergology
Aarhus N, Denmark
Start Date
December 1, 2019
Primary Completion Date
April 30, 2024
Completion Date
April 30, 2024
Last Updated
March 6, 2025
144
ACTUAL participants
Lead Sponsor
University of Aarhus
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions